Further comparative analyses of public datasets and qRT-PCR validation of newly diagnosed AML patients and healthy donors from Xinqiao Hospital revealed that METTL1 and WDR4 were significantly upregulated in both bone marrow and peripheral blood samples (Fig. 1B, C). The gene discussed is WDR4; the disease is acute myeloid leukemia.